Endorectal Ultrasound Versus MRI for Lower and Middle Rectal Cancer Staging in Upfront Surgery: A Comparative Study
Journal of Clinical Medicine · 16.04.2026 · 15 (8) · 3039
DOI: 10.3390/jcm15083039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 16.04.2026. Verfasst von Riccardo Balestri und 11 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Unit, New Santa Chiara Hospital, 56124 Pisa, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
This study aimed to compare the results obtained by endorectal ultrasound (ERUS) and magnetic resonance imaging (MRI) with the pathologic staging of the operative specimen in patients with lower and middle rectal cancer not treated with neoadjuvant therapy and undergoing surgery.
Methods
From 2011 to 2022, all the consecutive patients with lower/middle rectal cancer who underwent surgery-first treatment were evaluated. The results of diagnostic examinations and the definitive pathological examination were considered and compared.
Results
One hundred and one patients were enrolled in the study. The mean age was 72.5 (SD ± 9.7) years. F:M = 1:2. Mean distance from the anal orifice was 87 (SD ± 9.7) mm. Mean tumoral cranio-caudal extension was 35 (SD ± 12.5) mm. According to the T-stage, the κ coefficient showed a fair concordance between MRI and Pathology (κ = 0.294) and moderate between ERUS and Pathology (κ = 0.534). According to the N-stage, MRI was related to a lower concordance (κ = 0.138) than ERUS (κ = 0.337) with Pathology. Comparing ERUS with MRI, κ was higher in staging T (κ = 0.410), showing a moderate agreement. Stage N was related to a fair agreement between the two imaging methods (κ = 0.237).
Conclusions
MRI and ERUS have similar results in performing the TN staging in patients with lower and middle rectal cancer who did not undergo neoadjuvant chemoradiotherapy. ERUS might be a valid option for staging patients who cannot have the possibility to perform an MRI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- General Surgery Unit, New Santa Chiara Hospital, 56124 Pisa, Italy.
- General and Emergency Unit & Trauma Center, New Santa Chiara Hospital, University of Pisa, 56124 Pisa, Italy.
- Statistical Department, Pisa University, 56124 Pisa, Italy.
- Cisanello Radiology Unit, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.
ORCID-Profile: Riccardo Balestri, Mario Miccoli, Chiara Croce, Lucio Urbani, Piero Buccianti, Dario Tartaglia
Zitieren
APA
Balestri, R., Strambi, S., Giudice, F., Miccoli, M., Vagli, P., Croce, C., Urbani, L., Roffi, N., Arces, F., Buccianti, P., Chiarugi, M., & Tartaglia, D. (2026). Endorectal Ultrasound Versus MRI for Lower and Middle Rectal Cancer Staging in Upfront Surgery: A Comparative Study. Journal of Clinical Medicine, 15(8), 3039. https://doi.org/10.3390/jcm15083039
Vancouver
Balestri R, Strambi S, Giudice F, Miccoli M, Vagli P, Croce C, et al. Endorectal Ultrasound Versus MRI for Lower and Middle Rectal Cancer Staging in Upfront Surgery: A Comparative Study. Journal of Clinical Medicine. 2026;15(8):3039. doi:10.3390/jcm15083039
BibTeX
@article{Balestri2026,
author = {Balestri, Riccardo and Strambi, Silvia and Giudice, Francesco and Miccoli, Mario and Vagli, Paola and Croce, Chiara and Urbani, Lucio and Roffi, Niccolò and Arces, Francesco and Buccianti, Piero and Chiarugi, Massimo and Tartaglia, Dario},
title = {Endorectal Ultrasound Versus MRI for Lower and Middle Rectal Cancer Staging in Upfront Surgery: A Comparative Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {8},
pages = {3039},
doi = {10.3390/jcm15083039}
}
EUVIMED